对过敏性疾病,它们的流行病学趋势和管理障碍的全面审查
1Professor and HOD, Department of General Medicine, Deben Mahata Government Medical College and Hospital, Purulia, West Bengal, India, Corresponding Author.
The Journal of the Association of Physicians of India
|December 15, 2024
概括
全球范围内,过敏的患病率正在上升,影响着公众健康. 管理策略包括避免过敏原,药物治疗和免疫治疗,改善护理需要更多的培训和意识.
科学领域:
- 公共卫生 公共卫生
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 过敏代表着一个重要的全球公共卫生问题.
- 常见的过敏状况包括喘,鼻炎,结膜炎,亚托皮性湿疹,接触性皮肤炎和食物/药物过敏.
- 这篇文章提供了对过敏性疾病的全面概述.
研究的目的:
- 为了全面讨论过敏疾病.
- 检查过敏的流行病学趋势.
- 识别护理质量问题和管理障碍.
主要方法:
- 对过敏性疾病的流行病学数据的审查.
- 分析当前的管理策略.
- 讨论影响过敏护理质量的因素.
主要成果:
- 过敏性疾病在全球范围内呈现越来越高的流行率,但在某些特定地区出现了一些例外,例如喘的减少.
- 关键的控制方法包括过敏原暴露预防,药物治疗和免疫治疗.
- 有效的过敏管理存在障碍.
结论:
- 加强培训,研究和公众意识对于改善过敏护理至关重要.
- 解决管理障碍对于改善与过敏有关的公共卫生结果至关重要.
更多相关视频
相关概念视频
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236


